about the symposium
Now offering the option to present oral presentations virtually!
Geared towards research trainees and fellows, this half-day research symposium offers a unique opportunity to delve into the latest advancements, trends, and challenges shaping the field of cellular therapy.
All trainees are encouraged to submit an abstract describing their original basic science or translational research in the field of cellular therapy. Several abstracts will be selected for oral presentation with others presented during the poster session.
event details
Date: September 25, 2025
Time: 12:00PM-5:00PM CST
Location: David Rubenstein Forum
Format: In-person & Virtual Options
Registration: Free (Limited spots available)
Who Should Attend
Research Trainees
Fellows
Postdoctoral Researchers
Graduate Students
Early-Career Scientists
why should you attend?
Cutting-Edge Insights: Gain valuable insights into the cutting-edge research driving cellular therapy forward.
Oral/Poster Presentations: Showcase your own research and receive constructive feedback from peers and experts.
Interactive Sessions: Engage in interactive sessions including Q&A with leading researchers and clinicians.
Networking Opportunities: Connect with peers, mentors, and experts in the field to foster collaborations and exchange ideas.
Career Development: Learn about career opportunities and paths in cellular therapy research, and gain valuable advice from experienced professionals.
registration
Registration for the Jonas Center Cellular
Therapy Satellite Symposium for Research
Trainees is now open. Secure your spot today to
be part of this dynamic event!
Abstract Guidelines and Submission
The deadline for abstract submission for the
Jonas Center Cellular Therapy Satellite
Symposium for Research Trainees is
extended to August 25, 2025.
agenda
Course Directors:
Nathan Singh, MD, MS (WashU)
Justin Kline, MD (Univ. of Chicago)
Tyce Kearl, MD, PhD (MCW)
| Time | Agenda |
|---|---|
| 12:00 – 1:00PM | Lunch and Registration |
| 1:00 – 1:05PM | Welcome and Introductions Peter Riedell, MD University of Chicago |
| Oral Session 1 Faculty moderator: Justin Kline, MD University of Chicago | |
| 1:05 – 1:20PM | Incorporating the c-Myc 5’-UTR sequence impacts CD19 CAR T cell efficacy Lishi Xie, Ph.D University of Chicago |
| 1:20 – 1:35PM | LV20.19 CAR-T in PCNSL and SCNSL Anthony Stillwell, MS Medical College of Wisconsin |
| 1:35 – 1:50PM | Drugging BCL-2 in T cells to enhance anti-tumor cytotoxicity Jocelyn Hsu, BS University of Chicago |
| 1:50 – 2:05PM | IL-7 and IL-15 vs IL-2 for CD20/CD19 CAR-T expansion Md Shaheduzzaman, MS Medical College of Wisconsin |
| 2:05 - 2:25PM | |
| Oral Session 2 Faculty moderator: Tyce Kearl, MD, PhD Medical College of Wisconsin | |
| 2:25 – 2:40PM | TCRs with convergent recombination and somatic mutations persist in ovarian cancer Tomohiro Tate, Ph.D University of Chicago |
| 2:40 – 2:55PM | Identifying tumor-reactive T-cells against solid tumors Imaad Said, BS Medical College of Wisconsin |
| 2:55 – 3:10PM | iNK cells in GVHD prevention Kelsey Busken, MD, MSc WashU Medicine |
| 3:10 – 3:25PM | Anti-mp53 CD8TCR-therapy and CD4TCR prevents cancer relapse Ching-En Lee, MS University of Chicago |
| 3:25 – 3:45PM | BREAK |
| Oral Session 3 Faculty moderator: Nathan Singh, MD, MS WashU Medicine | |
| 3:45 – 4:00PM | PI3K inhibition in CAR-T Alexandra Rojek, MD University of Chicago |
| 4:00 – 4:15PM | Characterising the MR1-T cell axis in mycobacterium Idongesit Ekpo, BS University of Chicago |
| 4:15 – 4:30PM | CD47-CD138 BsAb in MM Maday Galeana Figueroa, MS Medical College of Wisconsin |
| 4:30 – 4:45PM | Mechanisms and impact of bystander killing by CAR T cells Joanna Chorazeczewski, MHS University of Chicago |
| 4:45 – 4:50PM | Closing Remarks Peter Riedell, MD University of Chicago |
| 4:50 – 5:30PM | Cocktails/Light Appetizers |
contact us
For inquiries or assistance with registration, please contact:
Leslie Brizendine
Email: Leslie@meetingachievements.com
Office: 219.465.1115